Welcome to SELECTBIO

SELECTBIO provides focused market reports, custom consultancy, recruitment, training courses and conferences to the life science marketplace. Specialising in early stage drug discovery and omics, we provide open forums for learning and networking, with the aim of fostering discussion and debate to advance disease research.

Conferences	Business Courses	Training Courses

Our specialist portfolio of global life science events provide attendees with a rich learning and networking environment where they can share and discuss the latest developments in their field. Ideal for professionals working in industry and academic settings within life science.	SELECTBIO business courses provide attendees with an up-to-date analysis of the life sciences, diagnostics and pharma-discovery space. Ideal for people involved in business planning processes and for those wishing to research and understand new market opportunities.	Keep up to date with emerging research techniques, technology developments and regulatory changes by attending one of our short courses or workshops.

Customer Testimonials

"I would like to say thank you for giving me an opportunity to participate in the European Lab Automation Congress. It was a pleasure to present my work; I also have met my old friends there and created new interesting contacts; got lots of ideas for my research."	"It was an interesting program with high qualified speakers and a good organization team."	“High quality of attendees/speakers and their presentation quality. Organisation was also very good”
European Lab Automation	Genomics Research Europe	Discovery Chemistry Congress
Natalie Kostesha, Technical University of Denmark	Ronald van Eijk, Laboratory Researcher, Leiden University Medical Center	Actelion Pharmaceuticals

Conference News

Harnessing the Great Promise of Microfluidics - an interview with Holger Becker
Dr Holger Becker, Chief Scientific Officer of microfluidic ChipShop GmbH, discusses the great potential of microfluidics in our latest blog entry – http://bit.ly/15HpwvN. Dr Becker will also be running a training course on ‘Microfluidics from the Concept to a Product: Technologies, Applications and Commercialisation Strategies’ at ELA on June 5th http://bit.ly/13ovJPE

The future of HCA using primary cells and 3D culture
This week’s ELA blog - http://bit.ly/15HpwvN -discusses the impact of process optimisation on cell based assays, with particular reference to High Content Analysis (HCA). To give us the inside scoop, we chatted with Dr Anthony Davies, Director of the High Content Research Facility at the Irish National Center for High Content Screening and Analysis (INCHSA) at Trinity College, Dublin, about the impact automation has had on the workflow at INCHSA. Dr Davies will also be sharing his expertise at E

5 Reasons Not to Miss ELA 2013
We understand that staying up-to-date on the latest technologies boosting efficiency and effectiveness in the lab can be challenging. That’s exactly why we created ELA. Our latest blog entry - http://bit.ly/15HpwvN - highlights five key reasons not to miss this year’s event, all based on feedback we’ve received from past attendees.

New ELA Blog
In the run up to European Lab Automation 2013, we’ll be sharing some interesting news and insights around the event on our new blog - http://tinyurl.com/aafeu9f . We’d be delighted if you’d like to comment on some of our blog posts, adding your own thoughts and generally become a valued part of the conversation!

Optimising NGS workflows – an interview with Dr Mike Quail, Team Leader at the Sanger Institute
In this week's blog entry - http://bit.ly/15HpwvN - Dr Quail gives us some insight into the current advances being made in NGS, as well as some of the challenges still facing the optimisation of NGS pipelines. Dr Quail will be speaking at ELA 2013 about the new NGS applications being developed at the Sanger Institute, as well as some of improvements his team are making to sequencing protocols.

The ethics around biobanking – an interview with Zubin Master
This week’s blog focusses on the ethical issues surrounding biobanking, based on a recent interview we conducted with Zubin Master. Dr Master, Assistant Professor at the Alden March Bioethics Institute of Albany Medical College, will be discussing this topic in detail at ELA 2013 as part of his presentation, “Biobanks: Consent, Consensus & Public Trust.”